The NUsurface implant addresses the current unmet clinical need for those with knee osteoarthritis who are too old or unwilling to have meniscal allograft transplantation yet are too young for total knee arthroplasty.
OUR BACKGROUND
A New Beginning on a Solid Foundation.
Phoenix Kinetics is the company rededicated to the success of a critical advancement in the preservation of motion and the biomechanical movement of forces through the knee.
- Founded by three former employees of Active Implants, LLC, Ryan Belaney, CEO, Adam Klyce, VP of Marketing & Communications, and Kirk Hanson, VP of Medical Education and Clinical Operations.
- “Phoenix” was chosen to invoke the symbolism of the rising phoenix; we adopt it as a symbol of the potential for growth through adversity and re-emerging transformed.
- “Kinetics,” one of the main branches of Dynamics, is concerned with the study of forces and motion; this represents the inspiration behind our passion for knee preservation.
OUR MISSION
The need for a treatment option for those with knee pain has never been greater.
The NUsurface implant squarely addresses the heart of this patient population, estimated to be over 1 million U.S. patients.
NUsurface addresses the current unmet clinical need for those with knee osteoarthritis who are too old or unwilling to have meniscal allograft transplantation yet are too young for total knee arthroplasty.
OUR RESULTS
Two NUsurface US clinical trials proved meaningful pain relief and improvement in function.
A series of clinical trials have verified patient-reported outcomes of consistent pain reduction, improvement in physical function, and overall quality of life in up to 80% of patients.
NUsurface clinical trial patients experienced:
- Significant, and lasting pain relief
- Improved physical function & quality of life
- Short procedure/limited blood loss
- Recovery in 6 weeks